Open-to-Accrual Therapeutic Trials

Genitourinary Oncology

Protocol ID

Official Title

PI Name

Lead CRC

Disease Site


CA01800f (Fraction-RCC) NCT02996110

A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-Oncology Study of Participants with Advanced Renal Cell Carcinoma J. Parikh Lisa Marshall & Kelly Jenkins Renal Cell Carcinoma II

S0931 (EVEREST) ClinicalTrials,gov: NCT01120249

EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study S. Ghamande Inquiries  Renal Cancer III